PanTheryx
Phoenix, US · 1 known investors
PanTheryx is a health and nutrition company that develops and commercializes consumer health supplements for the human health and wellness market, including products for digestive support and dietary needs.
Founders & leadership
FT
Feeley TomExecutive
GW
Gary Wes ThomasExecutive
WP
Wes ParrisExecutive
CL
Chris LindsayExecutive
GS
George StagnittiExecutive
Board
DC
David CogutBoard director
CC
Craig CogutBoard director
RS
Rajiv ShahBoard director
DA
David AbramsonBoard director
PE
Peter EricksonBoard director
HL
Holger LiepmannBoard director
MO
Mehmet OzBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$90.6M disclosed across 5 rounds · 2013–2023
▶$52.3MraisedOct 2023 · 1 investors · BiotechnologyRule 506(b)
▶$52.3MraisedOct 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- N Stuart HarrisDirector
- David CogutDirector
- Holger LiepmannDirector
- Thomas FeeleyExecutive Officer
- Wes ParrisExecutive Officer, Director
- David AbramsonDirector
- Peter EricksonDirector
- Offering amount
- $60M
- Amount sold
- $52.3M
- First sale
- Oct 2023
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
▶$9.4MraisedApr 2021 · 37 investors · BiotechnologyRule 506(b)
▶$9.4MraisedApr 2021 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David CogutDirector
- Feeley TomExecutive Officer
- Gary Wes ThomasExecutive Officer
- Rajiv ShahDirector
- David AbramsonDirector
- Wes ParrisExecutive Officer, Director
- Chris LindsayExecutive Officer
- Peter EricksonDirector
- Holger LiepmannDirector
- George StagnittiExecutive Officer
- Craig CogutDirector
- Mehmet OzDirector
- Offering amount
- $11.9M
- Amount sold
- $9.4M
- First sale
- Apr 2021
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
▶$10.7MraisedJul 2018 · 5 investors · BiotechnologyRule 506(b)
▶$10.7MraisedJul 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig CogutDirector
- James T. HauExecutive Officer
- Thomas WashingDirector
- Scott HymanExecutive Officer
- Peter J. VitulliDirector
- Mark A. BramanExecutive Officer, Director
- George StagnittiExecutive Officer
- David CogutDirector
- Offering amount
- $15M
- Amount sold
- $10.7M
- First sale
- Jul 2018
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
▶$8.9MraisedSep 2017 · 1 investors · BiotechnologyRule 506(b)
▶$8.9MraisedSep 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter J. VitulliDirector
- Mark A. BramanExecutive Officer, Director
- Thomas WashingDirector
- George StagnittiExecutive Officer
- David CogutDirector
- James T. HauExecutive Officer
- Craig CogutDirector
- Scott HymanExecutive Officer
- Offering amount
- $13M
- Amount sold
- $8.9M
- First sale
- Sep 2017
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
▶$9.3MraisedApr 2015 · 37 investors · BiotechnologyRule 506(b)
▶$9.3MraisedApr 2015 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas WashingDirector
- Mark A. BramanExecutive Officer, Director
- David J. CookDirector
- Scott HymanExecutive Officer
- George StagnittiExecutive Officer
- Offering amount
- $10M
- Amount sold
- $9.3M
- First sale
- Apr 2013
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does PanTheryx do?
- PanTheryx is a health and nutrition company that develops and commercializes consumer health supplements for the human health and wellness market, including products for digestive support and dietary needs.
- Who are PanTheryx's investors?
- PanTheryx's investors include PEGASUS CAPITAL.
- How much funding has PanTheryx raised?
- PanTheryx has disclosed $90.6M raised across 5 rounds.
- Where is PanTheryx headquartered?
- PanTheryx is headquartered in Phoenix, US.